Novavax
ID: 4386101Clinical stage biotechnology company focused on treating infectious diseases using recombinant nanoparticle vaccine technology
7
Funding Rounds
$2.4b
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Br** Mo**** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| St***** Er** | - | - | |
| Ja*** F. Yo*** | - | - | |
| Gr*** Al*** | - | - | linkedin twitter facebook |
| Ri***** Do***** | - | - | |
| Ra**** Ki** | - | - | |
| Ma****** G. Mc***** | - | - | |
| Mi***** A. Mc***** | - | - | |
| Da*** Mo** | - | - |
Funding
Funding series
Funding Series Analysis
The company Novavax has raised a total of $2.38b in funding over 7 rounds.
Key Insights:
- Novavax Grant (money), July 2020: $1.6b
- Novavax Private equity, June 2020: $200m
- Novavax Grant (money), May 2020: $384m
- Novavax Grant (money), March 2020: $4m
- Novavax Grant (money), September 2015: $89m
- Novavax Private equity, September 2013: $94.6m
- Novavax Venture round, June 2008: $5m
Industries
Novavax is active in the following industries: